Vail Health Behavioral Health
Welcome,         Profile    Billing    Logout  
 3 Trials 
3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Manager, Program
PROSPER, NCT06244771: A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Recruiting
1/2
403
US
FMC-376
Frontier Medicines Corporation
Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor, Metastatic Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer, KRAS G12C, Pancreatic Cancer
10/27
04/28
NCT05268666: A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

Recruiting
1/2
126
US
JBI-802
Jubilant Therapeutics Inc.
Locally Advanced Solid Tumor, Metastatic Solid Tumor
12/24
08/25
NCT06476275: Single Dose Texas 2017 (H3N2) Challenge Study

Active, not recruiting
1
33
US
Influenza A/Texas/71/2017 (H3N2), Sham placebo
Duke University, United States Department of Defense, Owlstone Ltd, Darwin Biosciences
Influenza Viral Infections
02/25
04/25
Sandler, Elaine
No trials found

Download Options